OQROGet OQRO Pro
Insider trade

Cytokinetics (CYTK)Director sold ~$37K

Wendall Wierenga, Director at Cytokinetics, sold ~$37K of Cytokinetics shares.

~$37K
Approx. value · 742 sh @ $50.00
25K
Holds after · shares reported
Traded
Nov 25, 2024
Filed
Nov 26, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2024Insider · 1 personInsiders: 2 sales (~$380K)
  2. Oct 9, 2024InsiderCEO sold ~$278K of CYTK shares in the open market
  3. Oct 15, 2024Insider · 1 personInsiders: 2 sales (~$396K)
  4. Oct 28, 2024InsiderDirector sold ~$233K of CYTK shares in the open market
  5. Oct 30, 2024Insider · 1 personInsiders: 2 sales (~$379K)
  6. Nov 1, 2024InsiderCEO sold ~$258K of CYTK shares in the open market
  7. Nov 12, 2024Insider · 1 personInsiders: 2 sales (~$371K)
  8. Nov 18, 2024InsiderCEO sold ~$253K of CYTK shares in the open market
  9. Nov 25, 2024 · this disclosureInsiderDirector sold ~$37K of CYTK shares in the open market

What came next

  1. Nov 26, 2024Insider · 1 personInsiders: 2 sales (~$366K)
  2. Dec 2, 2024InsiderCEO sold ~$254K of CYTK shares in the open market
  3. Dec 10, 2024Insider · 1 personInsiders: 2 sales (~$370K)
  4. Dec 11, 2024InsiderDirector sold ~$90K of CYTK shares in the open market
  5. Dec 16, 2024InsiderDirector sold ~$36K of CYTK shares in the open market
  6. Jan 7, 2025InsiderOfficer sold ~$99K of CYTK shares in the open market
  7. Jan 21, 2025InsiderOfficer sold ~$92K of CYTK shares in the open market
  8. Feb 4, 2025InsiderOfficer sold ~$96K of CYTK shares in the open market
  9. Feb 18, 2025InsiderOfficer sold ~$92K of CYTK shares in the open market
  10. Mar 3, 2025Insider · 3 peopleInsiders: 3 sales (~$528K)
  11. Mar 4, 2025Insider · 2 peopleInsiders: 2 sales (~$123K)
  12. Mar 5, 2025InsiderCEO sold ~$1.08M of CYTK shares in the open market
  13. Mar 6, 2025Insider · 3 peopleInsiders: 3 sales (~$1.2M)
  14. Mar 13, 2025InsiderOfficer sold ~$1.17M of CYTK shares in the open market
  15. Mar 14, 2025InsiderOfficer sold ~$4.5K of CYTK shares in the open market
  16. Mar 17, 2025Insider · 3 peopleInsiders: 5 sales (~$2.9M)
  17. Mar 18, 2025InsiderOfficer sold ~$87K of CYTK shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by Wendall Wierenga, Director

The full history of Wendall Wierenga, Director is on the profile page.

How this filing works

Other disclosures at Cytokinetics

Everything OQRO holds on this company is on its CYTK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data